Haleon plc (LON:HLN) Insider Acquires £24,825.80 in Stock

Haleon plc (LON:HLN) insider Blathnaid Bergin bought 6,145 shares of the firm’s stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average cost of GBX 404 ($5.41) per share, with a total value of £24,825.80 ($33,247.36).

Haleon Stock Up 0.8%

Shares of LON:HLN opened at GBX 409 ($5.48) on Wednesday. Haleon plc has a 1-year low of GBX 319.84 ($4.28) and a 1-year high of GBX 417.70 ($5.59). The company has a debt-to-equity ratio of 53.36, a current ratio of 0.84 and a quick ratio of 0.93. The stock has a market cap of £36.91 billion, a P/E ratio of 34.40, a P/E/G ratio of 1.49 and a beta of 0.19. The firm has a fifty day moving average price of GBX 386.53 and a 200 day moving average price of GBX 381.80.

Haleon (LON:HLN) last announced its earnings results on Friday, February 28th. The company reported GBX 15.80 ($0.21) earnings per share for the quarter. Haleon had a net margin of 9.66% and a return on equity of 6.54%. Sell-side analysts predict that Haleon plc will post 19.5033282 EPS for the current year.

Haleon Increases Dividend

The business also recently declared a dividend, which will be paid on Thursday, June 5th. Stockholders of record on Thursday, April 24th will be paid a dividend of GBX 4.60 ($0.06) per share. This represents a dividend yield of 1.18%. The ex-dividend date of this dividend is Thursday, April 24th. This is a boost from Haleon’s previous dividend of $2.00. Haleon’s dividend payout ratio is 50.46%.

Analyst Ratings Changes

Separately, Berenberg Bank boosted their price objective on Haleon from GBX 456 ($6.11) to GBX 457 ($6.12) and gave the company a “buy” rating in a research note on Friday, February 28th.

About Haleon

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.